Skip to main content

Coronavirus: Vaccination

Question for Department for Business, Energy and Industrial Strategy

UIN 130713, tabled on 16 December 2020

To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps were taken during the trial of the Pfizer covid-19 vaccine to test its effect on people with allergies.

Answered on

11 January 2021

The Pfizer/BioNTech vaccine has met the Medicines and Healthcare products Regulatory Agency’s robust standards of safety, quality, and effectiveness, and the safety data from the trials has set out how the COVID-19 vaccine works in different types of people. A robust and proactive safety monitoring strategy for COVID-19 vaccines is in place, which allows for rapid, real-time safety monitoring at population level.

Answered by

Department for Business, Energy and Industrial Strategy
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.